Nearly 1 in 4 patients undergoing surgery for early-stage breast cancer will require re-operation. Cancer requires re-operation so frequently because surgeons lack tools to detect cancerous tissue during the operation.
Lightpoint Medical is developing a novel molecular imaging technology to detect cancer in real-time during surgery. Our technology reduces the cost and size of a nuclear medicine scanner by 100-fold, enabling it to integrate into the operating room. Image-guided surgery has the potential to provide more accurate cancer treatment and thereby reduce the need for re-operation.